ATE83382T1 - Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. - Google Patents
Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.Info
- Publication number
- ATE83382T1 ATE83382T1 AT88909786T AT88909786T ATE83382T1 AT E83382 T1 ATE83382 T1 AT E83382T1 AT 88909786 T AT88909786 T AT 88909786T AT 88909786 T AT88909786 T AT 88909786T AT E83382 T1 ATE83382 T1 AT E83382T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroxyurea
- peptide
- interferon
- gamma
- active substances
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 229960001330 hydroxycarbamide Drugs 0.000 title 1
- VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 abstract 1
- 102000008070 Interferon-gamma Human genes 0.000 abstract 1
- 108010074328 Interferon-gamma Proteins 0.000 abstract 1
- 229940044627 gamma-interferon Drugs 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8713886A FR2621488B1 (fr) | 1987-10-08 | 1987-10-08 | Produit comprenant a titre de principes actifs a) un peptide ayant une activite du type de celle de l'interferon gamma humain, b) l'hyfroxyuree |
| EP88909786A EP0336958B1 (de) | 1987-10-08 | 1988-10-06 | Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff |
| PCT/FR1988/000496 WO1989003224A1 (fr) | 1987-10-08 | 1988-10-06 | Produit comprenant a titre de principes actifs: a) un peptide ayant une activite du type de celle de l'interferon gamma humain, b) l'hydroxyuree |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE83382T1 true ATE83382T1 (de) | 1993-01-15 |
Family
ID=9355622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88909786T ATE83382T1 (de) | 1987-10-08 | 1988-10-06 | Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0336958B1 (de) |
| JP (1) | JP2537677B2 (de) |
| AT (1) | ATE83382T1 (de) |
| CA (1) | CA1327745C (de) |
| DE (1) | DE3876788T2 (de) |
| FR (1) | FR2621488B1 (de) |
| WO (1) | WO1989003224A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2704546B2 (ja) * | 1989-04-04 | 1998-01-26 | 光利 太良 | Ａｔｌｌ治療用吸入剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3968249A (en) * | 1963-01-22 | 1976-07-06 | E. R. Squibb & Sons, Inc. | Method of treating malignant neoplastic disease |
-
1987
- 1987-10-08 FR FR8713886A patent/FR2621488B1/fr not_active Expired - Fee Related
-
1988
- 1988-10-06 EP EP88909786A patent/EP0336958B1/de not_active Expired - Lifetime
- 1988-10-06 DE DE8888909786T patent/DE3876788T2/de not_active Expired - Lifetime
- 1988-10-06 WO PCT/FR1988/000496 patent/WO1989003224A1/fr not_active Ceased
- 1988-10-06 JP JP63508971A patent/JP2537677B2/ja not_active Expired - Lifetime
- 1988-10-06 AT AT88909786T patent/ATE83382T1/de not_active IP Right Cessation
- 1988-10-07 CA CA000579590A patent/CA1327745C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0336958A1 (de) | 1989-10-18 |
| JPH02501484A (ja) | 1990-05-24 |
| JP2537677B2 (ja) | 1996-09-25 |
| FR2621488A1 (fr) | 1989-04-14 |
| CA1327745C (fr) | 1994-03-15 |
| DE3876788T2 (de) | 1993-07-01 |
| EP0336958B1 (de) | 1992-12-16 |
| WO1989003224A1 (fr) | 1989-04-20 |
| DE3876788D1 (de) | 1993-01-28 |
| FR2621488B1 (fr) | 1990-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68914835D1 (de) | Proteinerzeugnisse. | |
| DE3686018D1 (de) | Betriebsfuehrung von hardwaremitteln. | |
| ATE82835T1 (de) | Eiweissprodukt. | |
| DE3689974D1 (de) | Arzneimittel zur Behandlung von Emesis. | |
| FI874596L (fi) | Peptidpreparat. | |
| DE3789413D1 (de) | Lymphokin-ähnliche Peptide. | |
| NO873699L (no) | Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser. | |
| FI881418L (fi) | Syntetiska peptid antigener foer faststaellande av hiv-1 infektion. | |
| DE3852231D1 (de) | Anordnungen von infraroten Linsen. | |
| DE3885313D1 (de) | Peptide mit Laminin-Wirksamkeit. | |
| DE68909466D1 (de) | Zusammenwirkung von promotoren bei der pentennitril hydrocyanierung. | |
| DK174388D0 (da) | Cycliske peptider | |
| ATE109794T1 (de) | Von faktor vii abgeleitete peptide mit antihämostatischer wirkung. | |
| DK551287A (da) | Polypeptid | |
| DK171590A (da) | Vaskemiddelprodukt | |
| DE3765784D1 (de) | Zusammensetzung von aminosaeuren. | |
| DE3886517D1 (de) | Menschlicher Prourokinase ähnliches Polypeptid. | |
| DE68907392D1 (de) | Dysmnesie modifizierende arzneimittel. | |
| ATE83382T1 (de) | Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. | |
| FI900075L (fi) | Medvaexthormon bindande peptid. | |
| DK555189A (da) | Proteinprodukt | |
| FI854839A0 (fi) | Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid. | |
| DE68914161D1 (de) | Herstellung von prodrogen. | |
| DE68918742D1 (de) | Polyanhydridmodifizierte Addukte oder Reaktionsprodukte und diese enthaltende ölige Zubereitungen. | |
| DE3869939D1 (de) | Biologisch wirksame peptide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |